European Society of Gene and Cell Therapy: Difference between revisions
m moved European Society of Gene Therapy to European Society of Gene and Cell Therapy: changed their name recently to ESGCT |
m Moving from Category:Genetics organizations to Category:Genetics societies using Cat-a-lot |
||
(38 intermediate revisions by 26 users not shown) | |||
Line 1: | Line 1: | ||
'''European Society of Gene Therapy (ESGT)''' is a legally |
'''European Society of Gene & Cell Therapy (ESGCT)''' formerly '''European Society of Gene Therapy (ESGT)''' is a legally registered professional body which emerged from a small [[working group]] in 1992 that focused on human [[gene therapy]]. |
||
The objectives of the ESGT include the following: |
The objectives of the ESGT include the following: |
||
Line 13: | Line 13: | ||
==External links== |
==External links== |
||
*[http://www. |
*[http://www.esgct.eu/ Official Site] |
||
*[http://www.newswise.com/articles/view/516142/ Researchers from Israel, Southern California to Present Stem Cell Symposium] |
*[http://www.newswise.com/articles/view/516142/ Researchers from Israel, Southern California to Present Stem Cell Symposium] |
||
*[http://www.telegraph.co.uk/core/Content/displayPrintable.jhtml?xml=/connected/2003/11/19/ecnfibr18.xml&site=17 Researchers team up to tackle cystic fibrosis] |
*[http://www.telegraph.co.uk/core/Content/displayPrintable.jhtml?xml=/connected/2003/11/19/ecnfibr18.xml&site=17 Researchers team up to tackle cystic fibrosis] |
||
[[Category:Genetics]] |
[[Category:Genetics societies]] |
||
[[Category: |
[[Category:European medical and health organizations]] |
||
{{genetics-stub}} |
{{genetics-stub}} |
Latest revision as of 01:25, 6 May 2023
European Society of Gene & Cell Therapy (ESGCT) formerly European Society of Gene Therapy (ESGT) is a legally registered professional body which emerged from a small working group in 1992 that focused on human gene therapy.
The objectives of the ESGT include the following:
- promote basic and clinical research in gene therapy;
- facilitate education (and the exchange of information and technologies) related to gene transfer and therapy;
- serve as a professional adviser to the gene therapy community and various regulatory bodies in Europe.
The official journal of the ESGT is The Journal of Gene Medicine.
Collaborations[edit]
The ESGT works with other entities in the scientific communities in the event that an adverse effect to a specific gene therapy is discovered. Investigations the ESGT has been involved with include the adverse effects discovered during the French X-SCID gene therapy trial. The ESGT hosted a forum of 500 researchers from various facilities around the world, including representatives from the Stanford University and the Sloan Kettering Cancer Research Center.